Literature DB >> 12710949

Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study.

N E Riley1, F Bardag-Gorce, R O Montgomery, J Li, W Lungo, Y H Lue, S W French.   

Abstract

Mallory bodies are cytokeratin-ubiquitin aggresomes that form in hepatocytes in many different chronic liver diseases. One of the key components in aggresome formation, not yet investigated in Mallory body formation, is the role of microtubules. An in vitro tissue culture assay is required to test for microtubule involvement in Mallory body formation so that Mallory body formation can be observed in the presence or absence of microtubule-disrupting agents. In this report, a new model of in vitro Mallory body formation was developed, which uses cultured hepatocytes isolated from drug-primed mice. When hepatocytes were incubated in the presence of antimicrotubule agents, they failed to form Mallory bodies. It is concluded that intact microtubules are required for Mallory body formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710949     DOI: 10.1016/s0014-4800(03)00005-4

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  5 in total

Review 1.  The role of the ubiquitin proteasome pathway in keratin intermediate filament protein degradation.

Authors:  Micah R Rogel; Ariel Jaitovich; Karen M Ridge
Journal:  Proc Am Thorac Soc       Date:  2010-02

Review 2.  The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders.

Authors:  S W French; A S Mendoza; Y Peng
Journal:  Exp Mol Pathol       Date:  2016-04-09       Impact factor: 3.362

3.  S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory.

Authors:  Jun Li; Fawzia Bardag-Gorce; Jennifer Dedes; Barbara Alan French; Fataneh Amidi; Joan Oliva; Samuel William French
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

4.  Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter.

Authors:  Agnes Basseville; Akina Tamaki; Caterina Ierano; Shana Trostel; Yvona Ward; Robert W Robey; Ramanujan S Hegde; Susan E Bates
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

5.  Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis.

Authors:  Peter M Abuja; Kurt Zatloukal; Helmut Denk
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.